Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Clinical trial NCT04628767 · RECRUITING
Trial details
- NCT number
- NCT04628767
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-12
- Primary completion
- 2027-09-30
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.